Member News

ASPET announces new leadership

Bumpus, Ding, Boise and Linder to assume duties this summer
ASBMB Today Staff
May 16, 2022

Four members of the American Society for Biochemistry and Molecular Biology are poised to take leadership roles this summer in the American Society for Pharmacology and Experimental Therapeutics: Namandjé Bumpus, Xinxin Ding, Lawrence Boise and Maurine Linder.

Namandjé Bumpus

Namandjé Bumpus, a professor and director of the department of pharmacology and molecular sciences at Johns Hopkins University School of Medicine, has been elected president of ASPET. Her term will begin July 1.

Bumpus studies the metabolism of antiviral drugs used to treat HIV and hepatitis by the cytochromes P450 family of liver enzymes. Her lab uses pharmacogenomic and metabolomic approaches to understand why some antivirals cause drug-induced acute liver failure in hopes of developing future therapies that don’t carry the same risk of toxicity.

Bumpus earned her Ph.D. at the University of Michigan–Ann Arbor and was a postdoctoral researcher at Scripps Research. Her previous honors have included the Drug Metabolism Early Career award from ASPET, a young investigator award from the American Society for Clinical Pharmacology and Therapeutics, and the Presidential Early Career Award for Scientists and Engineers.

Xinxin Ding

Xinxin Ding, a professor and head of the department of pharmacology and toxicology at the University of Arizona College of Pharmacy, has been elected secretary/treasurer of ASPET.

Ding's research focuses on genetic and environmental risks for chemical toxicity. Recently, he has published on how inhaled naphthalene, which is used in moth balls, can cause genotoxicity and how bioactivation of toxicants in one organ can cause toxicity in another organ.

Ding earned his Ph.D. at the University of Michigan Medical School. He started his faculty career at the University at Albany, then worked at the State University of New York Polytechnic Institute before moving to Arizona in 2017.

Lawrence Boise

Lawrence Boise, a professor of hematology and medical oncology at Emory University School of Medicine and associate director for education and training at the Winship Cancer Institute, is to become secretary/treasurer for the society's division of cancer pharmacology.

Boise studies myeloma, a cancer of B cells. His lab conducts translational research to understand how gene expression in cancer cells governs their sensitivity to Bcl2 inhibitors, proteasome inhibitors and other classes of drug.

Boise earned a Ph.D. in pharmacology at the Medical College of Virginia and was a postdoc at the University of Michigan and the University of Chicago. Before joining the faculty at Emory, he was a professor and director of a graduate program in microbiology and immunology at the University of Miami Miller School of Medicine.

Maurine Linder

Maurine Linder, a professor and chair of the department of molecular medicine at Cornell University College of Veterinary Medicine, has been elected chair of the society's division for molecular pharmacology.

Linder studies the activity of DHHC acyltransferases, which carry out the post-translational modification protein S-palmitoylation. Her lab is interested in how palmitoylation affects signaling and how DHHC enzymes are themselves regulated through post-translational modification. 

Linder earned her Ph.D. at the University of Texas at Dallas and was a postdoc and later an instructor at the University of Texas Southwestern Medical Center. She was a professor at Washington University School of Medicine before joining the faculty at Cornell in 2009.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Related articles

Silence is not an option
ASBMB Today Staff
ASBMB welcomes new members
ASBMB Today Staff
ASBMB welcomes new members
ASBMB Today Staff
ASBMB welcomes new members
ASBMB Today Staff
ASBMB welcomes new members
ASBMB Today Staff

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Nights and days in the lab
BMB in Africa

Nights and days in the lab

June 23, 2022

With help from colleagues, mentors and others, Oluwaseyefunmi Adeniran pursues her dream of making scientific discoveries that improve human health.

A phage agent of change
BMB in Africa

A phage agent of change

June 22, 2022

Tolulope Oduselu, a student at the University of Ibadan in Nigeria, got hands-on research experience through a multinational program.

ASBMB names 2023 award winners
Announcement

ASBMB names 2023 award winners

June 21, 2022

Don’t miss their lectures at #DiscoverBMB in March in Seattle.

‘Life happens, but we keep pushing’
BMB in Africa

‘Life happens, but we keep pushing’

June 21, 2022

ASBMB member Adaude Amalunweze is a scientist and educator in Nigeria.

Protein Society announces 2022 awards
Member News

Protein Society announces 2022 awards

June 20, 2022

Among those recognized are ASBMB members Squire Booker, Daniel Herschlag and Nozomi Ando.

In memorian:  Nadrian Seeman
In Memoriam

In memorian: Nadrian Seeman

June 20, 2022

He was, a nanotechnologist who built the first self-assembling DNA structures and a member of the ASBMB since 1986.